Editorial
Colirios hipotensores: la historia interminable. ¿Hay que considerar algo más que los principios activos?
Hypotensive eyedrops: The neverending story. Should we consider more than active principles?
M.D. Pinazo-Durána,b,c,
, V. Zanón-Morenoa,b,c, R. Herrero Vanrellc,d, S.M. Sanz-Gonzáleza,b,c, J.J. García-Medinac,e,f, J. Benitez del Castillo Sánchezg
Autor para correspondencia
a Unidad de Investigación Oftalmológica «Santiago Grisolía»-Fundación FISABIO, Hospital Universitario Doctor Peset, Valencia, España
b Unidad de Oftalmobiología Celular y Molecular (UOCEM), Universidad de Valencia, Valencia, España
c Red Temática de Investigación Cooperativa en Patología Ocular (OFTARED), España
d Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, España
e Servicio de Oftalmología, Hospital General Universitario Reina Sofía, Murcia, España
f Departamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, Murcia, España
g Departamento de Oftalmología, Hospital de Jerez, Jerez de la Frontera, Cádiz, España
Leído
1831
Vecesse ha leído el artículo
1634
Total PDF
197
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 2 | 2 |
| 2025 11 | 0 | 12 | 12 |
| 2025 10 | 0 | 8 | 8 |
| 2025 9 | 0 | 8 | 8 |
| 2025 8 | 0 | 8 | 8 |
| 2025 7 | 0 | 10 | 10 |
| 2025 6 | 0 | 11 | 11 |
| 2025 5 | 0 | 10 | 10 |
| 2025 4 | 0 | 10 | 10 |
| 2025 3 | 0 | 26 | 26 |
| 2025 2 | 0 | 18 | 18 |
| 2025 1 | 0 | 23 | 23 |
| 2024 12 | 0 | 28 | 28 |
| 2024 11 | 0 | 10 | 10 |
| 2024 10 | 0 | 15 | 15 |
| 2024 9 | 0 | 26 | 26 |
| 2024 8 | 0 | 16 | 16 |
| 2024 7 | 0 | 10 | 10 |
| 2024 6 | 0 | 14 | 14 |
| 2024 5 | 0 | 9 | 9 |
| 2024 4 | 0 | 22 | 22 |
| 2024 3 | 0 | 26 | 26 |
| 2024 2 | 0 | 8 | 8 |
| 2024 1 | 0 | 16 | 16 |
| 2023 12 | 0 | 27 | 27 |
| 2023 11 | 0 | 15 | 15 |
| 2023 10 | 0 | 34 | 34 |
| 2023 9 | 0 | 5 | 5 |
| 2023 8 | 0 | 13 | 13 |
| 2023 7 | 0 | 27 | 27 |
| 2023 6 | 0 | 17 | 17 |
| 2023 5 | 0 | 23 | 23 |
| 2023 4 | 0 | 35 | 35 |
| 2023 3 | 1 | 35 | 36 |
| 2023 2 | 1 | 28 | 29 |
| 2022 1 | 0 | 123 | 123 |
| 2022 12 | 0 | 22 | 22 |
| 2022 11 | 0 | 18 | 18 |
| 2022 10 | 0 | 11 | 11 |
| 2022 9 | 0 | 29 | 29 |
| 2022 8 | 0 | 28 | 28 |
| 2022 7 | 0 | 15 | 15 |
| 2022 6 | 0 | 14 | 14 |
| 2022 5 | 0 | 13 | 13 |
| 2022 4 | 0 | 16 | 16 |
| 2022 3 | 0 | 13 | 13 |
| 2022 2 | 0 | 11 | 11 |
| 2021 1 | 0 | 9 | 9 |
| 2021 12 | 0 | 13 | 13 |
| 2021 11 | 0 | 15 | 15 |
| 2021 10 | 0 | 29 | 29 |
| 2021 9 | 0 | 19 | 19 |
| 2021 8 | 0 | 15 | 15 |
| 2021 7 | 0 | 10 | 10 |
| 2021 6 | 0 | 12 | 12 |
| 2021 5 | 0 | 24 | 24 |
| 2021 4 | 0 | 70 | 70 |
| 2021 3 | 0 | 32 | 32 |
| 2021 2 | 0 | 19 | 19 |
| 2020 1 | 0 | 22 | 22 |
| 2020 12 | 0 | 25 | 25 |
| 2020 11 | 0 | 16 | 16 |
| 2020 10 | 0 | 21 | 21 |
| 2020 9 | 1 | 6 | 7 |
| 2020 8 | 0 | 26 | 26 |
| 2020 7 | 0 | 10 | 10 |
| 2020 6 | 0 | 9 | 9 |
| 2020 5 | 0 | 24 | 24 |
| 2020 4 | 0 | 14 | 14 |
| 2020 3 | 0 | 12 | 12 |
| 2020 2 | 0 | 15 | 15 |
| 2020 1 | 0 | 27 | 27 |
| 2019 12 | 0 | 24 | 24 |
| 2019 11 | 0 | 6 | 6 |
| 2019 10 | 0 | 10 | 10 |
| 2019 9 | 0 | 14 | 14 |
| 2019 8 | 0 | 13 | 13 |
| 2019 7 | 0 | 15 | 15 |
| 2019 6 | 1 | 11 | 12 |
| 2019 5 | 0 | 52 | 52 |
| 2019 4 | 0 | 23 | 23 |
| 2019 3 | 0 | 2 | 2 |
| 2019 2 | 0 | 3 | 3 |
| 2019 1 | 0 | 5 | 5 |
| 2018 12 | 0 | 2 | 2 |
| 2018 11 | 0 | 9 | 9 |
| 2018 10 | 3 | 15 | 18 |
| 2018 9 | 1 | 0 | 1 |
| 2018 4 | 1 | 0 | 1 |
| 2018 2 | 22 | 3 | 25 |
| 2018 1 | 74 | 3 | 77 |
| 2017 12 | 14 | 0 | 14 |
| 2017 11 | 25 | 4 | 29 |
| 2017 10 | 1 | 0 | 1 |
| 2017 8 | 4 | 0 | 4 |
| 2017 7 | 3 | 0 | 3 |
| 2017 6 | 4 | 0 | 4 |
| 2017 5 | 39 | 1 | 40 |
| 2017 4 | 2 | 1 | 3 |
| 2017 2 | 0 | 6 | 6 |
Mostrar todo
